Get the Stockscreener App
2.0186
1.71%
-0.0314
Clover Health Investments Corp stock is traded at $2.0186, with a volume of 3.57M.
It is down -1.71% in the last 24 hours and down -23.67% over the past month.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
See More
Previous Close:
$2.05
Open:
$2.05
24h Volume:
3.57M
Relative Volume:
0.66
Market Cap:
$1.04B
Revenue:
$1.70B
Net Income/Loss:
$-123.70M
P/E Ratio:
-7.5802
EPS:
-0.2663
Net Cash Flow:
$-178.21M
1W Performance:
-1.23%
1M Performance:
-23.67%
6M Performance:
-19.40%
1Y Performance:
-54.92%
1-Day Range:
$2.01
$2.07
1-Week Range:
$2.01
$2.1899
52-Week Range:
$2.01
$4.80
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
(201) 432-2133
Address
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
2.02 | 1.06B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
283.31 | 252.65B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
77.95 | 97.99B | 402.11B | 1.73B | 7.81B | 1.3789 |
|
CI
Cigna Group
|
288.60 | 77.65B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
337.07 | 72.89B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
181.12 | 21.10B | 126.36B | 1.30B | 1.55B | 10.67 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Craig Hallum | Buy |
| Oct-07-24 | Initiated | UBS | Neutral |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
Clover Health stock hits 52-week low at $2.02 - Investing.com
Clover Health stock hits 52-week low at 2.12 USD By Investing.com - Investing.com Nigeria
Buy Signal: Is Clover Health Investments Corp showing insider buyingStock Surge & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Clover Health Investments (NASDAQ:CLOV) Downgraded by Wall Street Zen to Sell - MarketBeat
Not Many Are Piling Into Clover Health Investments, Corp. (NASDAQ:CLOV) Just Yet - 富途牛牛
Clover Health Investments, Corp. (NASDAQ:CLOV) Receives Average Rating of "Hold" from Analysts - MarketBeat
Can Clover Health Stock Rebound as Profitability Deadline Nears? - AD HOC NEWS
Dow Update: Does Clover Health Investments Corp have a competitive edge2025 Trade Ideas & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Clover Health Investments (NASDAQ:CLOV) Reaches New 52-Week LowTime to Sell? - MarketBeat
Clover Health jumps 19%; options activity could be why - MSN
Clover Health stock hits 52-week low at 2.12 USD - Investing.com
Clover Health On Track To Hit First Full-Year Profit In 2026 - RTTNews
Layoff Watch: Does Clover Health Investments Corp offer margin of safety2025 Market WrapUp & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - 富途牛牛
Flat Medicare Advantage Rates Put Clover Health Margins Under Fresh Scrutiny - Yahoo Finance
Clover Health rises as Medicare Advantage enrollments climb 53% - MSN
Clover Health Investments, Corp. to Release Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Quiver Quantitative
Clover Health (CLOV) Upgraded to Buy Amid Profitability Prospects - GuruFocus
Clover Health Investments (NASDAQ:CLOV) Trading Down 5.8%Time to Sell? - MarketBeat
Clover Health (CLOV) Slides As Trump Medicare Advantage Shock And UnitedHealth Earnings Hit Insurer Sentiment - Benzinga
Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 29.85% Potential Upside in Healthcare Plans - DirectorsTalk Interviews
Clover Health Is Undervalued With Clear Signs Of A 2026 Profit Breakout (NASDAQ:CLOV) - Seeking Alpha
Clover Health Balances Customer Growth And Cash Flow Against Revenue Pressure - Sahm
Investor Mood: Is NeuroSense Therapeutics Ltd stock a buy or sellEarnings Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Clover Health (CLOV): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
A Look At Clover Health (CLOV) Valuation After Optimistic Analyst Views And 2026 Profitability Target - simplywall.st
Clover Health CEO Reynoso sells $11860 in shares By Investing.com - Investing.com Canada
Clover Health CEO Reynoso sells $11860 in shares - Investing.com
Clover Health (CLOV) Stock Trades Up, Here Is Why - The Globe and Mail
Clover Health Shares Show Momentum as Analyst Reiterates Confidence - AD HOC NEWS
CLOV Analyst Rating: Canaccord Genuity Maintains 'Buy' with Pric - GuruFocus
Canaccord Genuity Group Reiterates Buy Rating for Clover Health Investments (NASDAQ:CLOV) - MarketBeat
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now - TradingView
CLOV reports MA membership growth, signals GAAP profitability in 2026 - MSN
Clover Health shares jump on 53% surge in Medicare Advantage membership - MSN
Published on: 2026-01-17 22:01:13 - baoquankhu1.vn
Traders Buy Large Volume of Put Options on Clover Health Investments (NASDAQ:CLOV) - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026 - The Globe and Mail
Clover Health Investments (NASDAQ:CLOV) Shares Down 4.8%Here's Why - MarketBeat
Clover Health Investments (CLOV) Is Up 12.4% After Surging Medicare Advantage Growth And 2026 Profit Outlook – Has The Bull Case Changed? - Yahoo Finance
Clover Health Investments, Corp. (CLOV): A Bull Case Theory - Finviz
A Look At Clover Health (CLOV) Valuation After Membership Surge And First Profit Outlook - Yahoo Finance
Clover Health reports 53% Medicare Advantage growth, eyes 2026 profitability - Investing.com Nigeria
Clover Health (CLOV) Sees 11% Stock Surge on Medicare Advantage Growth - GuruFocus
Clover Health (CLOV) Reports Significant Membership Growth for 2 - GuruFocus
Clover Health (CLOV) Shares Skyrocket, What You Need To Know - Finviz
Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November - Benzinga
ex991-pressreleasedatedj.htm - SEC.gov
Clover Health Investments (NASDAQ:CLOV) Shares Gap UpTime to Buy? - MarketBeat
Clover Health Stock Is Climbing Wednesday: What's Going On? - Benzinga
Clover Health Investments Corp Stock (CLOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.95%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):